SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-024739
Filing Date
2023-08-28
Accepted
2023-08-28 06:34:04
Documents
7
Period of Report
2023-10-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A acrx20230424_def14a.htm DEF 14A 1074968
2 acrx20230424_def14aimg002.jpg GRAPHIC 11215
3 b01.jpg GRAPHIC 6796
4 g01.jpg GRAPHIC 6682
5 g02.jpg GRAPHIC 63289
6 p01.jpg GRAPHIC 230341
7 p02.jpg GRAPHIC 165038
  Complete submission text file 0001437749-23-024739.txt   1742178
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35068 | Film No.: 231210034
SIC: 2834 Pharmaceutical Preparations